These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Vasoactive intestinal polypeptide (VIP) in the male genitourinary tract: concentration and motor effect. Larsen JJ; Ottesen B; Fahrenkrug J; Fahrenkrug L Invest Urol; 1981 Nov; 19(3):211-3. PubMed ID: 7298295 [TBL] [Abstract][Full Text] [Related]
43. The effects of oestrogen on urogenital health. Lachowsky M; Nappi RE Maturitas; 2009 Jun; 63(2):149-51. PubMed ID: 19410391 [TBL] [Abstract][Full Text] [Related]
44. Biphasic urethral sphincter responses to acetic acid infusion into the lower urinary tract in anesthetized cats. Chen Z; Anderson DL; Faison WL; Baer PG J Urol; 2001 Oct; 166(4):1539-48. PubMed ID: 11547128 [TBL] [Abstract][Full Text] [Related]
45. The cytology of the male urogenital tract: the effect of oestrogens. DE WAARD F Acta Endocrinol (Copenh); 1956 Sep; 23(1):79-88. PubMed ID: 13361799 [No Abstract] [Full Text] [Related]
46. Histopathology and histomorphometry of the urogenital tract in 15-month old male and female rats treated neonatally with SERMs and estrogens. Karlsson S Exp Toxicol Pathol; 2006 Aug; 58(1):1-12. PubMed ID: 16709447 [TBL] [Abstract][Full Text] [Related]
48. Role of thyroid hormones in human and laboratory animal reproductive health. Choksi NY; Jahnke GD; St Hilaire C; Shelby M Birth Defects Res B Dev Reprod Toxicol; 2003 Dec; 68(6):479-91. PubMed ID: 14745982 [TBL] [Abstract][Full Text] [Related]
49. [Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System]. Van Mil JW Ned Tijdschr Geneeskd; 1993 Jun; 137(24):1213-4. PubMed ID: 8391659 [No Abstract] [Full Text] [Related]
50. Detrusor dynamics. I. Effect of prostaglandin f2 alpha on tension-length relationship. Abdel-Rahman M; Coulombe A; Elhilali MM Invest Urol; 1981 Jan; 18(4):278-80. PubMed ID: 7451090 [TBL] [Abstract][Full Text] [Related]
51. Dosing and administration of ergotamine tartrate and dihydroergotamine. Mathew NT Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471 [TBL] [Abstract][Full Text] [Related]
52. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring. Smith P Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609 [TBL] [Abstract][Full Text] [Related]
53. [Comparative studies on the pharmacological properties of stereoisomers of ergotamine and dihydro-ergotamine]. Stadler PA; Stürmer E Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):457-8. PubMed ID: 4253876 [No Abstract] [Full Text] [Related]
55. Calcium entry blockade as a therapeutic principle in the female urogenital tract. Forman A Acta Obstet Gynecol Scand Suppl; 1984; 121():1-26. PubMed ID: 6588719 [No Abstract] [Full Text] [Related]
56. [Urogenital atrophy and recurrent urinary tract infection in elderly patients]. Salvat J; Capilna M; Schmidt MH Praxis (Bern 1994); 1997 Aug; 86(33):1249-53. PubMed ID: 9381010 [TBL] [Abstract][Full Text] [Related]
57. [Effect of dihydroergotamine on the urinary tract of experimenta animals]. Janiszewski B Pol Przegl Chir; 1966 Oct; 38(10):1203-7. PubMed ID: 5977234 [No Abstract] [Full Text] [Related]
58. Effects of ergotamine and dihydroergotamine on the resistance and capacitance vessels of skin and skeletal muscle in the cat. Stürmer E Postgrad Med J; 1976; 52suppl 1():32-9. PubMed ID: 959125 [No Abstract] [Full Text] [Related]